Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The cancer biological therapy market is influenced by an intricate interplay of factors determining its growth and development. Particularly, in recent times, this market has experienced a significant expansion due to advancements in medical research, prevalence of cancer as well as increased understanding of the molecular basis for the disease. They have demanded more efficient and personalized ways of dealing with the disease that are more precise than conventional methods such as chemotherapy.
Additionally, ever increasing number of new biological therapies is one among many drivers for market growth. In order to get specific cancer pathways and molecular markers different pharmaceutical and biotechnology companies are undertaking extensive researches on developing innovative drugs. This not just broadens treatment options available to patients but also intensifies competition within the industry through bringing about numerous advanced treatments. As a result, many players turn out competing for a competitive advantage through making discoveries in medicines.
Furthermore, global increase in cancer incidence rates has greatly affected market dynamics. An aging population together with environmental factors as well as change in lifestyle contribute to rise in cancer burden hence escalating demand for effective targeted therapies. The significance of these remedies for improving patient outcomes by government healthcare organizations is that they have been incorporated into protocols concerning treating cancer at an increasing rate. Consequently, there is an overwhelming acceptance and adoption which creates remarkable expansion in the overall biological therapy sector.
In addition market dynamics are influenced by regulatory changes taking place globally. Biological therapies pose unique challenges thus making regulatory authorities adapt while ensuring patient safety without hindering introduction of innovative drugs into the market. The speed at which new therapeutics enter into a given market mostly depends on how regulatory environment operates since it determines competitive position taken up by various firms operating therein.
Moreover; cost remains an important factor behind market dynamics regarding any particular type of cancer treatment (biological). These targeted approaches usually come with high costs which limit their wide spread application despite their tolerability compared to other forms of Cancer therapy .This concern is worldwide and attempts are being made to resolve pricing issues, facilitate affordability and enhance patients’ access. Market dynamics such as these result from the intersection of Healthcare policies with reimbursement mechanisms and pricing strategies.
Strategic alliances and partnerships have emerged within the pharmaceutical industry, among academic institutions, and research organizations in the market. The purpose of these collaborations is to combine expertise and resources so as to expedite drug development process, improve efficiency of clinical trials and bring novel treatments into the market swiftly. This kind of partnership creates a synergy that benefits all elements of an ecosystem in cancer biological therapy."
APAC Cancer Biological Therapy Market Highlights:
Market ScenarioÂ
The Asia Pacific Cancer Biological Therapy Market is expected to reach USD 172,450.2 Million by 2030 at 7.7% CAGR during the forecast period 2022-2030. Cancer is the leading and the second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and others. Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. Various types of biological therapies, which inhibit specific molecules involved in development and growth of cancer tumor, such therapies known as; cancer targeted therapies.
The major driving factors for Asia Pacific cancer biological therapy market are increasing cancer survival rates, growing demand for advanced therapies such as biological therapy, growth of cancer healthcare facilities in emerging countries, etc. Additionally, less number of side effects associated with biological therapy as compared to conventional treatment methods is the critical growth factor. Conventional cancer treatment methods like chemotherapy, radiotherapy give effective result, but along with that these methods also show its counter effects on body. The side effects may include, loss of hair, weakened immune system, and such others depending upon the type, and phase of cancer. Biological therapies help to reduce the level of side effects as compared to other treatment methods. Biological therapies are giving the same amount of success rate for curing the cancer patient with 1st stage cancer approximately 27% to 35%. Owing to low level of side effects and high success rate of this therapy, the market is expected to grow rapidly. However, high cost of the treatment may restrain the market growth.
Figure 1: Asia Pacific cancer biological therapy market, by types
 Sources: Annual reports, Press release, White paper, Company Presentation
Â
 Key Players The leading market players in the Asia Pacific cancer biological therapy market include Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Amgen Inc. (US), Bristol-Myers Squibb (US), Celgene (US), Eli Lilly and Company (US), EnGeneIC (Australia), Pfizer (US), Intas Pharmaceuticals Ltd. (India), and Sun Pharmaceutical Industries Ltd. (India)
Segmentation Asia Pacific cancer biological therapy market is segmented into types, phases, and end users.
On the basis of types the market is segmented into monoclonal antibodies, interferon, interleukins, cancer growth inhibitors, gene therapy, colony-stimulating factors, targeted therapy, cancer vaccines, and others. On the basis of phases, the market is segmented into phase I, phase II, and phase III.
On the basis of end users, the market is segmented into hospitals & clinics, cancer research centers, laboratories, and others.
Market Assessment 
Sources: Annual reports, World Health Organization (WHO), White paper, Company PresentationaÂ
Regional Analysis China dominates the Asia Pacific cancer biological therapy market owing to increasing prevalence of cancer. Increasing adoption of smoking by people, rapid research & development and presence rapidly developing economy in this region fuel the growth of the market in Asia Pacific. Japan and Australia are other major contributor to the market growth in this region.
Intended Audience
- Pharmaceutical Companies
- Pharmaceutical Suppliers
- Cancer Research Organizations
- Potential Investors
- Key Executive (CEO and COO) and Strategy Growth Manager
- Research Companies
Â
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
